First Time Loading...

Pharma Mar SA
MAD:PHM

Watchlist Manager
Pharma Mar SA Logo
Pharma Mar SA
MAD:PHM
Watchlist
Price: 36.72 EUR 1.32% Market Closed
Updated: May 19, 2024

Pharma Mar SA
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharma Mar SA
Interest Income Expense Peer Comparison

Comparables:
GRF
ORY
BST

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Mar SA
MAD:PHM
Interest Income Expense
€2.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Grifols SA
MAD:GRF
Interest Income Expense
-€332.3m
CAGR 3-Years
-68%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Oryzon Genomics SA
MAD:ORY
Interest Income Expense
-€1.6m
CAGR 3-Years
-48%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Biotechnology Assets SA
MAD:BST
Interest Income Expense
-€333.9k
CAGR 3-Years
2%
CAGR 5-Years
24%
CAGR 10-Years
N/A

See Also

What is Pharma Mar SA's Interest Income Expense?
Interest Income Expense
2.4m EUR

Based on the financial report for Mar 31, 2024, Pharma Mar SA's Interest Income Expense amounts to 2.4m EUR.